<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>A1417</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.amendfooter, li.amendfooter, div.amendfooter
	{mso-style-name:amendfooter;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>ASSEMBLY, No. 1417 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblywoman  SHAMA A. HAIDER</p>

<p class=bpuSponsor>District 37 (Bergen)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Requires county health departments to maintain
reserve stock of opioid antidotes to dispense to certain entities on interim
basis to ensure uninterrupted supply. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     Introduced Pending Technical Review by Legislative
Counsel.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> </span>concerning access to opioid antidotes and
amending P.L.2013, c.46.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.    Section 3 of P.L.2013,
c.46 (C.24:6J-3) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     3.    As used in this act:</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Commissioner&quot; means
the Commissioner of Human Services.</p>

<p class=MsoNormal style='line-height:150%'>     <u>County health department
means a county health department established pursuant to section 6 of the
Local Health Services Act, P.L.1975, c.329 (C.26:3A2-6).</u></p>

<p class=MsoNormal style='line-height:150%'>     &quot;Drug overdose&quot;
means an acute condition including, but not limited to, physical illness, coma,
mania, hysteria, diminished consciousness, respiratory depression, or death
resulting from the consumption or use of a controlled dangerous substance or
another substance with which a controlled dangerous substance was combined and
that a layperson would reasonably believe to require medical assistance. </p>

<p class=MsoNormal style='line-height:150%'>     &quot;Emergency medical
response entity&quot; means an organization, company, governmental entity,
community-based program, or healthcare system that provides pre-hospital
emergency medical services and assistance.  &quot;Emergency medical response
entity&quot; includes, but is not limited to, a first aid, rescue and ambulance
squad or other basic life support (BLS) ambulance provider; a mobile intensive
care provider or other advanced life support (ALS) ambulance provider; an air
medical service provider; or a fire-fighting company or organization, which
squad, provider, company, or organization is qualified to send paid or
volunteer emergency medical responders to the scene of an emergency.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Emergency medical
responder&quot; means a person, other than a health care practitioner, who is
employed on a paid or volunteer basis in the area of emergency response,
including, but not limited to, an emergency medical technician, a mobile
intensive care paramedic, or a fire fighter, acting in that person's
professional capacity.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Health care
practitioner&quot; means any individual who is licensed or certified to provide
health care services pursuant to Title 45 of the Revised Statutes.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Institution of higher
education&quot; means any public or private university, college, technical
college or community college located in New Jersey.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Law enforcement
agency&quot; means a department, division,</p>

<p class=MsoNormal style='line-height:150%'>bureau, commission, board or other
authority of the State or of any political subdivision thereof which employs
law enforcement officers.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Law enforcement
officer&quot; means a person whose public duties include the power to act as an
officer for the detection, apprehension, arrest and conviction of offenders
against the laws of this State.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Medical assistance&quot;
means professional medical services that are provided to a person experiencing
a drug overdose by a health care practitioner, acting within the practitioner's
scope of professional practice, including professional medical services that
are mobilized through telephone contact with the 911 telephone emergency
service.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Occupational
school&quot; means a business, trade, technical, or other school approved by a
nationally-recognized accrediting agency.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Opioid antidote&quot;
means any drug, regardless of dosage amount or method of administration, which
has been approved by the United States Food and Drug Administration (FDA) for
the treatment of an opioid overdose.  &quot;Opioid antidote includes, but is
not limited to, naloxone hydrochloride, in any dosage amount, which is
administered through nasal spray or any other FDA-approved means or methods.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Prescriber&quot; means a
health care practitioner authorized by law to prescribe medications. 
&quot;Prescriber&quot; includes, but shall not be limited to, physicians,
physician assistants, and advanced practice nurses.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Public library&quot;
means a library that serves, free of charge, all residents of an area without
discrimination and that receives its financial support, in whole or in part,
from public funds.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Public transportation
hub&quot; means a passenger station, terminal, or other facility, as designated
by the Commissioner of Transportation, where public transportation services are
made available. </p>

<p class=MsoNormal style='line-height:150%'>     &quot;Recipient&quot; means
any individual who or entity that is prescribed or dispensed an opioid antidote
in accordance with section 4 of P.L.2013, c.46 (C.24:6J-4) or section 1 of
P.L.2017, c.88 (C.45:14-67.2).  The term &quot;recipient&quot; shall include,
but shall not be limited to, private citizens, emergency medical responders,
emergency medical response entities, law enforcement officers, law enforcement
agencies, <u>county health departments and employees of county health
departments,</u> recognized places of public access, employees and volunteers
providing services at, through, or on behalf of a recognized place of public
access, public and nonpublic schools, school nurses and other staff at a public
or nonpublic school, sterile syringe access programs, and staff and employees
of a sterile syringe access program.  The term &quot;recipient&quot; shall not
include a prescriber or a licensed pharmacist acting within a professional
capacity.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Recognized place of
public access&quot; means a public library, institution of higher education,
occupational school, or public transportation hub.</p>

<p class=MsoNormal style='line-height:150%'>     <u>&quot;School&quot; means a
public or nonpublic elementary or secondary school within this State offering
education in grades kindergarten through 12, or any combination of grades, at
which a child may legally fulfill compulsory school attendance requirements.  School
shall not include an occupational school.</u></p>

<p class=MsoNormal style='line-height:150%'>     &quot;Sterile syringe access
program&quot; means a program established pursuant to the provisions of
P.L.2006, c.99 (C.26:5C-25 et al.).  </p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2021, c.152, s.2)</p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.    Section 4 of P.L.2013,
c.46 (C.24:6J-4) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     4.    a.  (1) A prescriber or
other health care practitioner, as appropriate, may prescribe or dispense an
opioid antidote directly or through a standing order to any person or entity. 
Any person or entity may be dispensed an opioid antidote pursuant to an
individual prescription or a standing order issued by a prescriber, and any
person or entity may be dispensed an opioid antidote by a pharmacy as provided
in section 1 of P.L.2017, c.88 (C.45:14-67.2).</p>

<p class=MsoNormal style='line-height:150%'>     (2)   Nothing in P.L.2013,
c.46 (C.24:6J-1 et al.) shall be construed to restrict in any way the ability
of any individual or entity to be dispensed an opioid antidote.  The persons
and entities to whom an opioid antidote may be prescribed and dispensed shall
include private citizens, individuals who are dispensed an opioid antidote for
administration or distribution to others in either a private or professional
capacity, entities that are dispensed opioid antidotes on behalf of individuals
who administer or distribute opioid antidotes to others in the course of their
professional duties, and entities other than a prescriber or pharmacist that
maintain a stock of opioid antidotes for distribution or administration to
others.</p>

<p class=MsoNormal style='line-height:150%'>     (3)   (Deleted by amendment,
P.L.2021, c.152).</p>

<p class=MsoNormal style='line-height:150%'>     (4)   (Deleted by amendment,
P.L.2021, c.152).</p>

<p class=MsoNormal style='line-height:150%'>     b.    (1)  A recipient in
possession of an opioid antidote may administer the opioid antidote to any
other person, without fee, in any situation in which the recipient reasonably
believes the other person to be experiencing an opioid overdose. </p>

<p class=MsoNormal style='line-height:150%'>     (2)   A recipient in
possession of an opioid antidote may distribute the opioid antidote, without
fee, to any other person who the recipient reasonably believes to be at risk of
experiencing an opioid overdose or who the recipient reasonably believes will
be in a position to administer the opioid antidote to a person experiencing an
opioid overdose.  A recipient distributing an opioid antidote to another person
pursuant to this paragraph shall make reasonable efforts to furnish the person
with the overdose prevention information described in section 5 of P.L.2013,
c.46 (C.24:6J-5).  The Commissioner of Health, or, if the commissioner is not a
duly licensed physician, the Deputy Commissioner for Public Health Services,
shall issue a standing order authorizing the distribution of opioid antidotes
pursuant to this paragraph.</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)  A prescriber or
other health care practitioner who prescribes or dispenses an opioid antidote
in good faith, and in accordance with the provisions of this section, shall
not, as a result of the practitioner's acts or omissions, be subject to any
criminal or civil liability, or any professional disciplinary action under
Title 45 of the Revised Statutes, for prescribing or dispensing the opioid
antidote.  A pharmacist that dispenses an opioid antidote in good faith, in
accordance with the provisions of this section or section 1 of P.L.2017, c.88
(C.45:14-67.2), shall not, as a result of the pharmacist's acts or omissions,
be subject to any criminal or civil liability, or any professional disciplinary
action under Title 45 of the Revised Statutes, for dispensing the opioid
antidote.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   A recipient who
administers or distributes an opioid antidote in good faith as provided in
subsection b. of this section shall not, as a result of any of the recipient's
acts or omissions, be subject to any criminal or civil liability, or any
professional disciplinary action, for administering or distributing the opioid
antidote.</p>

<p class=MsoNormal style='line-height:150%'>     d.    (Deleted by amendment,
P.L.2021, c.152).</p>

<p class=MsoNormal style='line-height:150%'>     e.     The immunity provided
by this section for persons who are engaged in prescribing, dispensing,
distributing, or administering an opioid antidote shall be coextensive with the
immunity provided under sections 7 and 8 of P.L.2013, c.46 (C.2C:35-30 and
C.2C:35-31), to the extent that the provisions of those sections apply.</p>

<p class=MsoNormal style='line-height:150%'>     f.     (Deleted by amendment,
P.L.2021, c.152).</p>

<p class=MsoNormal style='line-height:150%'>     g.    (Deleted by amendment,
P.L.2021, c.152).</p>

<p class=MsoNormal style='line-height:150%'>     h.    (Deleted by amendment,
P.L.2021, c.152).</p>

<p class=MsoNormal style='line-height:150%'>     <u>i.     (1)  Each county
health department shall obtain, through a standing order, and maintain in an
accessible storage location, a reserve stock of opioid antidotes sufficient to
ensure an uninterrupted supply of opioid antidotes is available to law
enforcement agencies, emergency medical response entities, schools, and hospital
pharmacies operating in the county.  The quantity of opioid antidotes that are
to be kept in reserve stock by each county health department pursuant to this
subsection shall be determined by the director of the county health department,
in consultation with the county prosecutor, the county association of police
chiefs, and the county association of fire chiefs, and with input from law
enforcement agencies, emergency medical response entities, school districts, schools,
and hospitals operating in the county.  </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   In the event that a
law enforcement agency, emergency medical response entity, school, or hospital
pharmacy anticipates that it will exhaust its<i> </i>supply of opioid antidotes
before it will be able to acquire an additional supply pursuant to a standing
order issued pursuant to subsection a. of this section, the law enforcement
agency, emergency medical response entity, or school may make a request to the
county health department to provide the requester with an interim supply of
opioid antidotes from the county health departments reserve stock.  Upon
receipt of a request, the county health department shall promptly deliver to
the requester an interim supply of opioid antidotes in a quantity sufficient to
ensure that the requester will be able to continue administering or
distributing opioid antidotes, as applicable, during the interim period between
the date the requesters supply of opioid antidotes is expected to be exhausted
and the date the requester expects to receive a new stock of opioid antidotes
pursuant to a standing order.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(3)   A law enforcement
agency, emergency medical response entity, school, or hospital pharmacy that
obtains an interim supply of opioid antidotes from a county health departments
reserve stock pursuant to this subsection shall reimburse the county health
department for the departments actual costs to acquire and deliver the interim
supply.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(4)   County health
departments in the State may enter into shared service agreements, in
accordance with the Uniform Shared Services and Consolidation Act, sections 1
through 35 of P.L.2007, c.63 (C.40A:65-1 through C.40A:65-35), in order to facilitate
the acquisition of opioid antidotes at discounted rates, minimize delivery
costs, and otherwise facilitate the implementation of this subsection.</u></p>

<p class=MsoNormal style='line-height:150%'> (cf: P.L.2021, c.152, s.3)</p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    (New section) The Commissioner
of Human Services shall adopt rules and regulations, pursuant to the
Administrative Procedure Act, P.L.1968, c.410 (C.52:14B-1 et seq.), as shall
be necessary to implement the provisions of this act.  </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4.    This act shall take
effect immediately.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill amends the Overdose
Prevention Act, P.L.2013, c.42 (C.24:6J-1 et seq.), to require each county
health department to obtain and maintain in an accessible storage location, a
reserve stock of opioid antidotes that can be accessed by law enforcement
agencies, emergency medical response entities, schools, and hospital pharmacies
to ensure those entities have access to an uninterrupted supply of opioid
antidotes.  The exact quantity of opioid antidotes to be maintained in the reserve
stock will be determined by the director of each county health department in
consultation with the county prosecutor, the county association of police
chiefs, and the county association of fire chiefs, and with input from law
enforcement agencies, emergency medical response entities, hospitals, school
districts, and schools operating in that county.  </p>

<p class=MsoNormal style='line-height:150%'>     The bill specifies that,
whenever a law enforcement agency, emergency medical response entity, school,
or hospital pharmacy anticipates it will exhaust its supply of opioid antidotes
before it is able to acquire more, it may make a request to the county health
department to provide an interim supply of opioid antidotes from the county
health departments reserve stock.  Upon receiving a request, the county health
department will be required to promptly deliver to the requester an interim
supply sufficient to meet the requesters need for opioid antidotes for the
interim period between the date the requesters supply is expected to be
exhausted and the date the requester expects to receive a new supply of opioid
antidotes by regular means.</p>

<p class=MsoNormal style='line-height:150%'>     Law enforcement agencies, emergency
medical response entities, schools, and hospital pharmacies that obtain an
interim supply of opioid antidotes from a county health departments reserve
stock will be required to reimburse the county health department for the departments
actual costs in acquiring and delivering the interim supply.  The bill
expressly authorizes county health departments to enter into shared service
agreements, in accordance with the Uniform Shared Services and Consolidation
Act, in order to facilitate the acquisition of opioid antidotes at discounted
rates, minimize delivery costs, and otherwise facilitate the implementation of
the provisions of the bill.</p>

</div>

</body>

</html>
